| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis
|
Giannakeas, Vasily
|
|
2018
|
169 |
3 |
p. 587-594
|
artikel
|
| 2 |
Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
|
Jacobs, D. H. M.
|
|
2018
|
169 |
3 |
p. 549-559
|
artikel
|
| 3 |
A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer
|
Rudolph, M.
|
|
2018
|
169 |
3 |
p. 457-467
|
artikel
|
| 4 |
Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18–64 years in BCBS of Texas
|
Kim, Junghyun
|
|
2018
|
169 |
3 |
p. 573-586
|
artikel
|
| 5 |
Breast cancer subtype and survival by parity and time since last birth
|
De Mulder, H.
|
|
2018
|
169 |
3 |
p. 481-487
|
artikel
|
| 6 |
Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes
|
Zarei, Neda
|
|
2018
|
169 |
3 |
p. 427-436
|
artikel
|
| 7 |
Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes
|
Zarei, Neda
|
|
|
169 |
3 |
p. 427-436
|
artikel
|
| 8 |
Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy
|
Chang, Ji Hyun
|
|
2018
|
169 |
3 |
p. 507-512
|
artikel
|
| 9 |
Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013
|
Shoemaker, Meredith L.
|
|
2018
|
169 |
3 |
p. 595-606
|
artikel
|
| 10 |
Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial
|
Aalders, Kim C.
|
|
2018
|
169 |
3 |
p. 497-505
|
artikel
|
| 11 |
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
|
Dehdashti, Farrokh
|
|
2018
|
169 |
3 |
p. 523-530
|
artikel
|
| 12 |
Factors associated with improved outcomes for metastatic inflammatory breast cancer patients
|
Weiss, Anna
|
|
2018
|
169 |
3 |
p. 615-623
|
artikel
|
| 13 |
First international TNBC conference meeting report
|
Rida, Padmashree
|
|
2018
|
169 |
3 |
p. 407-412
|
artikel
|
| 14 |
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial
|
Janni, Wolfgang
|
|
2018
|
169 |
3 |
p. 469-479
|
artikel
|
| 15 |
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer
|
Miyake, Kanae K.
|
|
2018
|
169 |
3 |
p. 437-446
|
artikel
|
| 16 |
Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis
|
Goldvaser, Hadar
|
|
2018
|
169 |
3 |
p. 413-425
|
artikel
|
| 17 |
Is invasion a necessary step for metastases in breast cancer? Narod SA, Sopik V
|
Hollingsworth, Alan B.
|
|
2018
|
169 |
3 |
p. 633-637
|
artikel
|
| 18 |
Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population
|
Schairer, Catherine
|
|
2018
|
169 |
3 |
p. 607-614
|
artikel
|
| 19 |
MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine
|
Xie, Bingbing
|
|
2018
|
169 |
3 |
p. 625-632
|
artikel
|
| 20 |
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
|
Wagner, Lynne I.
|
|
2018
|
169 |
3 |
p. 537-548
|
artikel
|
| 21 |
Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial
|
Skaane, Per
|
|
2018
|
169 |
3 |
p. 489-496
|
artikel
|
| 22 |
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
|
Lammert, Jacqueline
|
|
2018
|
169 |
3 |
p. 561-571
|
artikel
|
| 23 |
Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy
|
Tolkach, Yuri
|
|
2018
|
169 |
3 |
p. 447-455
|
artikel
|
| 24 |
Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?
|
Narod, Steven A.
|
|
2018
|
169 |
3 |
p. 639-640
|
artikel
|
| 25 |
Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
|
Harvey, James R.
|
|
2018
|
169 |
3 |
p. 531-536
|
artikel
|
| 26 |
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
|
Costa, Ricardo L. B.
|
|
2018
|
169 |
3 |
p. 397-406
|
artikel
|
| 27 |
The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
|
Collarino, Angela
|
|
2018
|
169 |
3 |
p. 513-522
|
artikel
|
Tijdschrift beschrijving